Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
GDRX · Nasdaq · United States · Services-Computer Processing & Data Preparation
In shortGoodRx Holdings, Inc. is profitable, generates cash and carries moderate debt, with revenue stable (+0.6% last year).
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 11.0% | 53/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 3.8% | 35/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 4.5% | 23/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 4.3% | 28/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.61× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.79× | 67/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.31× | 77/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 2.05× | 5/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -0.18 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 20.6% | 100/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 5.40× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 2 of 5 | 40/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 15.3% | 54/100 |
| Operating margin volatility | 6.0% | 55/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 1.3% | 24/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
3 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 745 | 767 | 750 | 792 | 797 |
| Research & development | 126 | 143 | 136 | 124 | 121 |
| Operating income | 13 | 1.7 | (27) | 66 | 87 |
| Interest expense | 24 | 34 | 57 | 53 | 43 |
| Pre-tax income | (10) | (23) | (56) | 31 | 57 |
| Income tax | 15 | 9.6 | (47) | 15 | 26 |
| Net income | (25) | (33) | (8.9) | 16 | 30 |
| Diluted EPS | −$0.06 | −$0.08 | −$0.02 | $0.04 | $0.09 |
| Diluted shares (millions) | 410 | 413 | 410 | 392 | 357 |
3 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of GoodRx Holdings, Inc. are included in the Investor plan. Try free for 7 days →
−0.18 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026